The study revealed several key findings:

• A single 25mg dose of psilocybin led to measurable alterations in brain structure.
• Participants exhibited a surge in brain entropy within an hour of taking psilocybin.
• Changes in brain structure were still apparent one month post-dose.

Prof. Robin Carhart-Harris commented, “It’s remarkable to see potential anatomical brain changes one month after a single dose of any drug.” This research underscores the growing interest in psychedelics as a therapeutic avenue for mental health.

The study comes at a time when the Functional Mushroom Council, established in 2025, is unifying North American growers and suppliers. Recent innovations include:

• M2 Ingredients introducing M2Brew, a functional mushroom ingredient for brewed coffee.
• Fungi Perfecti launching product lines like Grateful Dead Gummies and Host Defense Gummies.
• Monterey Nutra releasing ManeFocus, a premium Lion’s Mane extract.

This wave of innovation reflects a commitment to bridging the gap between people and fungi. A company spokesperson noted, “By leading with science, quality, and collaboration, the Council aims to elevate the role of functional mushrooms in food, beverage, and wellness.” With ongoing research into psychedelics and their effects on brain structure, the future holds promise for enhanced mental health treatments.

The post Mushroom Innovations: Psilocybin’s Impact on Brain Structure appeared first on NewsUK.